Rollins Q2 Miss Seen as Seasonal, H2 Recovery Expected, Morgan Stanley Says

MT Newswires Live
07/24

Rollins' (ROL) Q2 results fell short of expectations as a slower-than-usual start to the peak summer pest season weighed on organic revenue growth, though Morgan Stanley expects performance to improve in the second half of the year.

The brokerage said in a Thursday note that weaker-than-expected organic revenue growth reflected softer residential digital lead volumes, particularly at Orkin. However, lead volumes recovered in late June and remained strong through July, while healthy customer retention, pricing and underlying consumer demand point to a stronger third quarter.

Morgan Stanley expects easier year-over-year comparisons and favorable El Nino-driven weather to support H2 growth but lowered its 2026 adjusted EBITDA estimate by 4% following the Q2 miss and lower expected Q3 incremental margins.

Management said business trends strengthened toward the end of June and into July, according to the report.

Morgan Stanley maintained its overweight rating on the stock and cut its price target to $60 from $65.

Rollins shares were down 2.1% in Friday trading.

Price: 38.61, Change: -0.83, Percent Change: -2.10

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10